摘要
目的观察胸腺肽在预防糖尿病患者反复出现皮肤疖、痈的治疗作用。方法选用60例2011—2014年该院门诊及住院糖尿病同时合并皮肤疖、痈患者,糖化血红蛋白在6%~7%,空腹血糖：7 mmol/L以下,餐后血糖10 mmol/L以下。随机分为2组（每组30人）,胸腺肽α1（海南中和药业有限公司,商品名称：和日单剂1.6 mg）治疗组,非治疗组,治疗时间为12个月,以复发皮肤疖、痈患者数评估胸腺肽治疗效果。结果应用胸腺肽α1治疗组皮肤疖、痈无复发。结论：胸腺肽α1对于预防糖尿病反复皮肤疖痈有显著作用。
Objective Observe the Thymic Peptideal in prevent diabetes patients with repeatedly skin furuncle、carbuncle treatment function.Methods Select 60 example 2011-2014 our hospital clinic and hospitalized diabetes patients with skin furuncle、carbuncle,glycosylated hemoglobin 6-7%,blood-fasting sugar 7mmol/L below,postprandial blood sugar 10mmol/L below,random divide two group（each group 30 peoples）,Thymic Peptideaal（zhonghe product medicine corporation hainan.commodity name heri dose 1.6mg） treat group and non-treat group,cure time 12 months,according to the amount with repeatedly skin furuncle、carbuncle as effective.Results Skin furuncle、carbuncle in Thymic Peptideaal treat group no recurrence.Conclusion Thymic peptideal to preventing diabetes skin furuncle carbuncle have a significant effect.
出处
《糖尿病新世界》
2016年第15期129-130,共2页
Diabetes New World Magazine
关键词
胸腺肽
糖尿病
皮肤感染
Thymic Peptideα1
Diabetes
Skin furuncle
